Abstract

Abstract Microfluidic impedance flow cytometry (IFC) enables high-throughput single-cell analysis in label-free manner. Tens of thousands of cells can be measured in several minutes under multiple frequencies, which give rise to impedance features with rich information ideal for machine learning (ML)-based cell classification. Conventional data processing approach for IFC typically exploits the scattered distribution of the measured cells which correlates the impedance features (e.g., the impedance amplitude and phase at different frequencies, the amplitude ratio between high to low frequencies) and exhibits resolved cell clusters in scatter plot. By manually gating on the distributed dots plot, the cell subgroups get mapped to different cell type or cellular states. ML-based data processing for IFC not only reduces the human workload, and more importantly, it also eliminates the human interference to manual gating strategy, and thus potentially leading to more concise and accurate cell classification results. Here, we demonstrate the ML-based classification of different cell states for tumor cells subject to anticancer drug treatment. IFC-measured impedance data of H1650 cells and Hela cells under drug-induced mitosis block state and apoptosis state have been applied for ML-based cell state identification. Three machine learning models, including the random forest (RF), support vector machine (SVM) and K-nearest neighbours (KNN) have been trained for impedance features extracted from cell signals at both 500 kHz and 10 MHz. In comparison, the RF model give rise to the highest classification accuracies among all trained models here. For H1650 cells, 84.01% and 85.96% accuracies have been respectively achieved for G1/S state vs. apoptosis and G2/M vs. apoptosis. For the classification between G2/M vs. apoptosis for the paclitaxel-treated Hela cells, the RF model produces high accuracy of 98.70%.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.